MabPlex International locks in $59.1 mln Series A

China and California-based MabPlex International Ltd, a contract development and manufacturing organization for the global biopharmaceutical and biotechnology industries, has secured $59.1 million in Series A funding. China’s State Development & Investment Corporation and Shenzhen Venture Capital were the lead investors.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!